SIROLIMUS vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. SIROLIMUS and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SIROLIMUS	TASIGNA
Rating	66/100	70/100
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	NILOTINIB HYDROCHLORIDE
Manufacturer	Apotex	Novartis
Dosage forms	Solution	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

sirolimus tasigna

Rating

66/100

70/100

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

NILOTINIB HYDROCHLORIDE

Manufacturer

Apotex

Novartis

Dosage forms

Solution

Capsule

Drug class

Kinase Inhibitor

Boxed warning

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

Which is better-rated, Sirolimus or Tasigna?

By our independent rating, Tasigna scores higher — 3.5 vs 3.3 out of 5 for Sirolimus. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Sirolimus and Tasigna?

Sirolimus contains Sirolimus, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.